- Home
- RNXT vs MLSS Comparison
RNXT vs MLSS Comparison
Compare RNXT & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- MLSS
- Stock Information
- Founded
- RNXT 2012
- MLSS 1989
- Country
- RNXT United States
- MLSS United States
- Employees
- RNXT N/A
- MLSS N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- RNXT Health Care
- MLSS Health Care
- Exchange
- RNXT Nasdaq
- MLSS Nasdaq
- Market Cap
- RNXT 44.6M
- MLSS 42.4M
- IPO Year
- RNXT 2021
- MLSS 1995
- Fundamental
- Price
- RNXT $1.26
- MLSS $0.54
- Analyst Decision
- RNXT Strong Buy
- MLSS Buy
- Analyst Count
- RNXT 2
- MLSS 1
- Target Price
- RNXT $7.50
- MLSS $1.25
- AVG Volume (30 Days)
- RNXT 648.4K
- MLSS 61.1K
- Earning Date
- RNXT 11-12-2025
- MLSS 11-13-2025
- Dividend Yield
- RNXT N/A
- MLSS N/A
- EPS Growth
- RNXT N/A
- MLSS N/A
- EPS
- RNXT N/A
- MLSS N/A
- Revenue
- RNXT $662,000.00
- MLSS $9,083,205.00
- Revenue This Year
- RNXT $2,895.35
- MLSS $17.24
- Revenue Next Year
- RNXT $313.04
- MLSS $14.58
- P/E Ratio
- RNXT N/A
- MLSS N/A
- Revenue Growth
- RNXT N/A
- MLSS 7.84
- 52 Week Low
- RNXT $0.75
- MLSS $0.38
- 52 Week High
- RNXT $1.69
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- RNXT 58.65
- MLSS 37.62
- Support Level
- RNXT $1.19
- MLSS $0.55
- Resistance Level
- RNXT $1.45
- MLSS $0.65
- Average True Range (ATR)
- RNXT 0.12
- MLSS 0.04
- MACD
- RNXT 0.02
- MLSS -0.01
- Stochastic Oscillator
- RNXT 62.75
- MLSS 6.50
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.